Cosby Stone, MD MPH
Vanderbilt University Medical Center

Douglas Johnston, DO FAAAAI
Asthma & Allergy Specialists, P.A.

Efficacy of Lanadelumab in Hereditary Angioedema Patients With and Without Prior Use of Long-Term Prophylaxis: Final Results From the HELP Open-Label Extension Study
Jonathan Bernstein, MD FAAAAI
Bernstein Allergy Group, Inc

Pregnancy and infant outcomes among pregnant women with Chronic Spontaneous Urticaria (CSU) treated with omalizumab: a descriptive analysis from the EXPECT pregnancy registry
Jennifer Namazy, MD FAAAAI
Scripps Clinic

Skin Macrophages Drive Immune Dysregulation in Atopic Dermatitis
Sabine Islam, MD
Massachusetts General Hospital

Berotralstat Reduces Use of On-demand Medication in Hereditary Angioedema (HAE) Patients Previously Treated with Prophylactic Therapies
Richard Gower, MD FAAAAI
Marycliff Clinical Research

Safety and Outcomes for Penicillin Skin Testing in Pregnancy
Vima Patel, MD
Rutgers- RWJUH IM Residency

Efficacy and Safety of Abrocitinib in Adolescent Patients With Moderate-to-Severe Atopic Dermatitis (AD): Results From the Phase 3 JADE TEEN study
Lawrence Eichenfield
University of California, San Diego

Application of a Physiologically Based Modeling to Increase the Knowledge on Epinephrine Absorption from A Novel Nasal Spray (ARS-1) In Healthy Adults
Jeff Barrett, PhD
Critical Path Institute

NTLA-2002: CRISPR/Cas9-mediated gene knockout of KLKB1 to treat hereditary angioedema
Jessica Seitzer
Intellia Therapeutics

Safety and Outcomes of 2-step Non-steroidal Anti-inflammatory Drug Provocation Tests in the Outpatient Setting
Lily Li, MD
Brigham & Women's Hospital